A report from GHTC and Policy Cures Research examines how US federal funding for global health R&D is delivering impact both abroad and at home.

Search the GHTC website

News

News
PATH/Gabe Bienczycki
October 24, 2019

GHTC responds to RFI on National Vaccine Action Plan

GHTC submitted comments to a US Department of Health and Human Services request for information (RFI) on the 2020 National Vaccine Action Plan (NVP). GHTC’s submission encouraged the continuation of R&D objectives reflected in the 2010 NVP and recommended additional areas of focus including strengthening public-private partnerships, advancing regulatory science, ensuring sustainable financing for areas that lack commercial market demand, promoting access-centered R&D, and collaborating with international partners to strengthen laboratory and clinical trial capacity.

Read time: 6 minutes / PDF link
Flickr/Kent MacElwee
October 23, 2019

GHTC endorses STOP Neglected Diseases of Poverty Act

GHTC endorsed the STOP (Study, Treat, Observe, and Prevent) Neglected Diseases of Poverty Act, a piece of legislation introduced by Senator Cory Booker (D-NJ) aimed at advancing the tools necessary to address and ultimately eliminate neglected disease of poverty in the United States.

Read time: 5 minutes / External link
October 21, 2019

Play: TRICK or TREATment?

To enjoy a bit of fun and mischief this Halloween, we’ve created a game, TRICK or TREATment, to test our readers’ knowledge of global health technologies.

Written by Marissa Chmiola / GHTC
Read time: 8 minutes
One of the great things about working at GHTC is that every day we get to read stories about incredible innovations in global health. Most of the technologies we read about are inventive, some are revolutionary, and a few are so unusual, one might think they were ripped from the pages of a science fiction novel. So, to enjoy a bit of fun and mischief this Halloween, we’ve created a new game, TRICK or TREATment, to test our readers’ knowledge of global health technologies. For each question, we will present a description of a global health technology. Choose TREATment if you believe this innovation exists and has market approval. Choose TRICK if you think we are trying to pull one over on you and, instead, the product is still in development or just a figment of our imagination.  Loading... (function(i, s, o, g, r, a, m) { var ql = document.querySelectorAll('A[quiz],DIV[quiz],A[data-quiz],DIV[data-quiz]'); if (ql) { if (ql.length) { for (var k = 0; k
CDC/James Gathany
October 21, 2019

GHTC Statement on the Okayama Declaration of the G20 Health Ministers Meeting

The Global Health Technologies Coalition is greatly encouraged that yesterday’s Okayama Declaration from G20 Health Ministers contains strong support for investing in research and development initiatives to combat antimicrobial resistance and improve public health preparedness.

Read time:
The Global Health Technologies Coalition (GHTC) is greatly encouraged that yesterday’s Okayama Declaration from G20 Health Ministers contains strong support for investing in research and development (R&D) initiatives to combat antimicrobial resistance (AMR) and improve public health preparedness.Global health R&D has consistently produced new advances that address major challenges facing the world today. That’s especially evident in the recent breakthroughs in fighting Ebola and drug-resistant tuberculosis. The G20 Health Ministers are sending an important signal that R&D continues to be critical for driving solutions to emerging threats. Drug-resistant infections alone would take 10 million lives by 2050 unless we move quickly to develop new solutions. Thus, we applaud the G20’s ongoing support for the Global AMR R&D Hub and continued investments in R&D for antimicrobials, diagnostics and vaccines. We’re also pleased to see GHTC member organization FIND recognized for its contributions in advancing diagnostics, which are essential for detecting, diagnosing and monitoring drug-resistant infections.The health declaration from the G20 can provide much-needed direction and momentum for ongoing efforts to achieve the 2030 Sustainable Development Goals (SDGs), and particularly SDG3, which is aimed at ensuring healthy lives for all. We applaud the Health Ministers for the timely recognition that R&D will be critical for dealing with rising threats and creating a more just and equitable world.